# Strategy for Improving Stroke Treatment Response

Study · id `cardio:ct-nct05948566` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05948566](<https://clinicaltrials.gov/study/NCT05948566>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05948566

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 300 participants.

## Technical summary

Registry record NCT05948566. Randomized; quadruple masking; primary purpose treatment. Start 2024-03-18 (actual); primary completion 2028-07 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 300 participants (planned count; ClinicalTrials.gov record NCT05948566, source copy `cardio:ctgov-nct05948566-2026-10-19`, retrieved 2026-10-26)
- Started: 2024-03-18 (actual) (ClinicalTrials.gov record NCT05948566, source copy `cardio:ctgov-nct05948566-2026-10-19`, retrieved 2026-10-26)
- Primary completion: 2028-07 (anticipated) (ClinicalTrials.gov record NCT05948566, source copy `cardio:ctgov-nct05948566-2026-10-19`, retrieved 2026-10-26)
- Completion: 2028-12 (anticipated) (ClinicalTrials.gov record NCT05948566, source copy `cardio:ctgov-nct05948566-2026-10-19`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT05948566, source copy `cardio:ctgov-nct05948566-2026-10-19`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05948566-2026-10-19`, retrieved 2026-10-26)

## The registry's words

- Brief title: Strategy for Improving Stroke Treatment Response
- Acronym: SISTER
- Condition: Ischemic Stroke
- Intervention (Biological): TS23
- Lead sponsor: Translational Sciences, Inc.
- Lead sponsor class: INDUSTRY
- Collaborator: University of Cincinnati
- Collaborator class: OTHER
- Collaborator: National Institute of Neurological Disorders and Stroke (NINDS)
- Collaborator class: NIH
- Collaborator: Medical University of South Carolina
- Collaborator class: OTHER
- Collaborator: University of Arizona
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as a collaborator: University of Cincinnati (`cardio:org-university-of-cincinnati`)
- Registry lists this organization as a collaborator: National Institute of Neurological Disorders and Stroke (`cardio:ninds`)
- Registry lists this organization as a collaborator: Medical University of South Carolina (`cardio:org-medical-university-of-south-carolina`)
- Registry lists this organization as a collaborator: University of Arizona (`cardio:org-university-of-arizona`)

## Provenance

Content hash: 9f022f9516c49bea98cf4721ba1703bdbcfc70e9b2354956909a80d2bccbf465
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
